These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 10608480)
1. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee. J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480 [TBL] [Abstract][Full Text] [Related]
2. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee. Chalmers J; Neal B; MacMahon S; J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785 [TBL] [Abstract][Full Text] [Related]
3. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee. J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716 [TBL] [Abstract][Full Text] [Related]
4. Stroke secondary prevention and blood pressure reduction: an observational study of the use of PROGRESS therapy. Bugnicourt JM; Chillon JM; Canaple S; Lamy C; Godefroy O Fundam Clin Pharmacol; 2008 Apr; 22(2):217-22. PubMed ID: 18353116 [TBL] [Abstract][Full Text] [Related]
5. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. PROGRESS Collaborative Group Lancet; 2001 Sep; 358(9287):1033-41. PubMed ID: 11589932 [TBL] [Abstract][Full Text] [Related]
6. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Dufouil C; Chalmers J; Coskun O; Besançon V; Bousser MG; Guillon P; MacMahon S; Mazoyer B; Neal B; Woodward M; Tzourio-Mazoyer N; Tzourio C; Circulation; 2005 Sep; 112(11):1644-50. PubMed ID: 16145004 [TBL] [Abstract][Full Text] [Related]
7. Global impact of stroke. Chalmers J Heart Dis; 2000; 2(2):S13-7. PubMed ID: 11728258 [TBL] [Abstract][Full Text] [Related]
8. PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997. PROGRESS Management Committee. J Hum Hypertens; 1998 Sep; 12(9):627-9. PubMed ID: 9783492 [TBL] [Abstract][Full Text] [Related]
9. [Effects of blood pressure lowering treatment on stroke recurrence in patients with cerebrovascular diseases-a large-scale, randomized, placebo controlled trial]. Liu LS; Gong LS; Wang W; Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):613-7. PubMed ID: 16080808 [TBL] [Abstract][Full Text] [Related]
10. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B; Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420 [TBL] [Abstract][Full Text] [Related]
11. [ADVANCE: a morbidity mortality study of diabetes and hypertension]. Heim A; Feihl F; Waeber B Rev Med Suisse; 2008 Jan; 4(139):28, 30, 32-3. PubMed ID: 18251212 [TBL] [Abstract][Full Text] [Related]
12. Making PROGRESS in stable patients post stroke or transient ischaemic attack: implications for general practice. Jackson G Int J Clin Pract; 2003 Jun; 57(5):385-7. PubMed ID: 12846342 [TBL] [Abstract][Full Text] [Related]
13. An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event. Tavakoli M; Pumford N; Woodward M; Doney A; Chalmers J; MacMahon S; Macwalter R Eur J Health Econ; 2009 Feb; 10(1):111-9. PubMed ID: 18446392 [TBL] [Abstract][Full Text] [Related]
14. Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial. Fransen M; Anderson C; Chalmers J; Chapman N; Davis S; MacMahon S; Neal B; Sega R; Terent A; Tzourio C; Woodward M; Stroke; 2003 Oct; 34(10):2333-8. PubMed ID: 12958329 [TBL] [Abstract][Full Text] [Related]
16. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M; Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247 [TBL] [Abstract][Full Text] [Related]
17. [Reduced risk of stroke recurrence due to hypotensive medication, irrespective of the initial blood pressure]. Lenders JW; Thien T Ned Tijdschr Geneeskd; 2002 Mar; 146(9):398-9. PubMed ID: 11901939 [TBL] [Abstract][Full Text] [Related]
18. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials. Brugts JJ; Ninomiya T; Boersma E; Remme WJ; Bertrand M; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML Eur Heart J; 2009 Jun; 30(11):1385-94. PubMed ID: 19346520 [TBL] [Abstract][Full Text] [Related]
19. Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee. Tzourio C; Anderson C; J Hypertens Suppl; 2000 May; 18(1):S21-4. PubMed ID: 10939786 [TBL] [Abstract][Full Text] [Related]
20. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Tzourio C; Anderson C; Chapman N; Woodward M; Neal B; MacMahon S; Chalmers J; Arch Intern Med; 2003 May; 163(9):1069-75. PubMed ID: 12742805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]